South Wales, Jan. 23 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "Alceus" on Jan. 5. The details about the trademark application no. UK00004319006 published in the journal no. 2026/004 (Jan. 23).
Alceus Biosciences Ltd filed the trademark application for the below mentioned good(s)/service(s).
Class 5 : Medical and veterinary preparations for therapeutic purposes; preparations for cell therapy; preparations for gene therapy; preparations for cancer therapies; preparations for autoimmune diseases; chimeric antigen receptors (CAR) and therapeutic preparations thereof; antibodies; preparations for genetically modifying human or animal cells for medical purposes, including viral vectors; preparations of blood extracted from humans or animals which have been adapted for therapeutic purposes; pharmaceutical preparations; pharmaceutical preparations for use in the treatment of cancer; pharmaceutical preparations for use in the treatment of autoimmune diseases; biological preparations for the treatment of cancer; biological preparations for use in the treatment of autoimmune diseases; pharmaceutical and biological preparations for immunotherapy, including T cell therapy; gene therapy.
Class 42 : Scientific and technological services and research and design relating thereto; industrial analysis and research services; research services including the manipulation of cells within a laboratory or research facility to enable the cells to be used for therapeutic purposes; scientific research in the development of autoimmune diseases and new cancer therapies; scientific research in human and animal cell therapy; scientific research in human and animal gene therapy; scientific research into vectors and preparations for manipulating and adapting human and animal cells.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004319006
Disclaimer: Curated by HT Syndication.
